Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat

Journal of Hypertension

Volumn 24, Issue 9, 2006, Pages 1865-1872

  Blanton, Ahmad ^a   Nsaif, Rami ^a   Hercule, Hantz ^a   Oyekan, Adebayo ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

20 hydroxyeicosatetraenoic acid; Cyclosporin A; Cytochrome P450; Nitric oxide; Preglomerular vessel

Indexed keywords

1 AMINOBENZOTRIAZOLE; 20 HYDROXYICOSATETRAENOIC ACID; ARGININE; BRADYKININ; CYCLOSPORIN A; CYTOCHROME P450; ENDOTHELIN 1; FORMAMIDINE; HET 0016; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLOMERULUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY MICROSOME; MALE; MICROVASCULATURE; NEPHROTOXICITY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VASOCONSTRICTION; VASODILATATION;

EID: 33747380254     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000242412.88653.f2     Document Type: Article

References (31)

1. Takenaka T, Hashimoto Y, Epstein M. Diminished acetylcholine-induced vasodilation in renal microvessels of cyclosporin-treated rats. J Am Soc Nephrol 1992; 3:42-50.
2. Perico N, Remuzzi A, Imberti O, Cavallotti D, Bertani T, Remuzzi G. Morphometrical analysis of glomerular changes induced by cyclosporin in the rat. Am J Kidney Dis 1991; 17:537-543.
3. Oriji GK, Kaiser HR. Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 1998; 32:849-855.
4. Zhang W, Li JL, Hosaka M, Janz R, Shelton JM, Albright GM, et al. Cyclosporin A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci U S A 2000; 97:9765-9770.
5. Lassila M. Interaction of cyclosporin A and the renin-angiotensin system: new perspectives. Curr Drug Metab 2002; 3:61-71.
6. Rezzani R, Rodella L, Bianchi R. Induction of endothelin in rat kidney after cyclosporin A treatment. Acta Histochem 2001; 103:423-431.
7. Darlametsos IE, Papanikolaou EN, Varonos DD. Effect of nifedipine in cyclosporin-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems. Prostagland Leukot Essent Fatty Acids 2000; 63:263-269.
8. Averna M, Barbagallo CM, Ganci A, Giammarresi C, Cefalu AB, Sparacino V, et al. Determinants of enhanced thromboxane biosynthesis in renal transplantation. Kidney Int 2001; 59:1574-1579.
9. Wang C, Ford P, Chao C, Chao L, Chao J. Effect of cyclosporin A on the expression of tissue kallikrein, kininogen and bradykinin receptor in rat. Am J Physiol 1997; 273:F783-F789.
10. Kurus M, Esrefoglu M, Bay A, Ozturk F. Protective effect of oral L-arginine supplementation on cyclosporine-induced nephropathy in rats. Int Urol Nephrol 2005; 37:587-594.
11. Lessio C, de Assuncao Silva F, Gloria MA, Di Tommaso AB, Gori Mouro M, Di Marco GS, et al. Cyclosporine A and NAC on the inducible nitric oxide synthase expression and nitric oxide synthesis in rat renal artery cultured cells. Kidney Int 2005; 68:2508-2516.
12. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci U S A 1993; 90:11147-11151.
13. Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC. Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest 1999; 104:1131-1137.
14. Morgan ET, Ullrich V, Daiber A, Schmidt P, Takaya N, Shoun H, et al. Cytochromes P450 and flavin monooxygenases - targets and sources of nitric oxide. Drug Metab Dispos 2001; 29:1366-1376.
15. Seki T, Ishimoto T, Sakurai T, Yasuda Y, Taniguchi K, Doi M, et al. Increased excretion of urinary 20-HETE in rats with cyclosporine-induced nephrotoxicity. J Pharmacol Sci 2005; 97:132-137.
16. Vickers AE, Alegret M, Meyer E, Smiley S, Guertler J. Hydroxyethyl cyclosporin A induces and decreases P4503A and P-glycoprotein levels in rat liver. Xenobiotica 1996; 26:27-39.
17. Alonso-Galicia M, Drummond HA, Reddy KK, Falck JR, Roman RJ. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 1997; 29:320-325.
18. Sato M, Ishii T, Kobayashi-Matsunaga Y, Amada H, Tanigushi K, Miyata N, Kameo K. Discovery of a N′-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. Bioorg Med Chem Lett 2001; 11:2993-2995.
19. Lopez B, Moreno C, Salom MG, Roman RJ, Fenoy FJ. Role of guanylyl cyclase and cytochrome P-450 on renal response to nitric oxide. Am J Physiol Renal Physiol 2001; 281:F420-F427.
20. Hercule HC, Oyekan AO. Cytochrome P450 omega/omega-1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole. J Pharmacol Exp Ther 2000; 292:1153-1160.
21. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82:131-185.
22. Vetter M, Chen Z-J, Chang G-D, Che D, Liu S, Chang C-H. Cyclosporin A disrupts bradykinin signaling through superoxide. Hypertension 2003; 41:1136-1142.
23. Fink J, Fan NY, Rosenfeld L, Stier CT Jr. Contribution of endothelin to the acute pressor response of L-NAME in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 1998; 31:618-622.
24. Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB, Bahou WF. Termination of endothelin signaling: role of nitric oxide. J Cell Physiol 1994; 158:485-494.
25. Wilasrumee C, Da Silva M, Siddiqui J, Bruch D, Kittur S, Wilasrumee S, Kittur DS. Role of endothelin-1 in microvascular dysfunction caused by cyclosporine A. J Am Coll Surg 2003; 196:584-591.
26. Oyekan AO, McGiff JC. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat. Am J Physiol 1998; 274:R52-R61.
27. Lariviere R, Day R, Schiffrin EL. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1993; 21:916-920.
28. Zhao H, Joshua IG, Porter JP. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 2000; 13:819-826.
29. Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 2002; 39:690-694.
30. Imig JD, Falck JR, Wei S, Capdevila JH. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J Vasc Res 2001; 38:247-255.
31. Udosen IT, Jiang H, Hercule HC, Oyekan AO. Nitric oxide-epoxygenase interactions and arachidonate-induced dilation of rat renal microvessels. Am J Physiol Heart Circ Physiol 2003; 285:H2054-H2063.